Insuline Medical W7 (ANSL_t7) SWOT Analysis / TOWS Matrix / MBA Resources
Strategy / MBA Resources
Introduction to SWOT Analysis
SWOT Analysis / TOWS Matrix for Insuline Medical W7 (Israel)
Based on various researches at Oak Spring University , Insuline Medical W7 is operating in a macro-environment that has been destablized by – challanges to central banks by blockchain based private currencies, there is increasing trade war between United States & China, wage bills are increasing, technology disruption, there is backlash against globalization, digital marketing is dominated by two big players Facebook and Google, customer relationship management is fast transforming because of increasing concerns over data privacy,
increasing inequality as vast percentage of new income is going to the top 1%, banking and financial system is disrupted by Bitcoin and other crypto currencies, etc
Introduction to SWOT Analysis of Insuline Medical W7
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University, we believe that Insuline Medical W7 can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Insuline Medical W7, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Insuline Medical W7 operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of Insuline Medical W7 can be done for the following purposes –
1. Strategic planning of Insuline Medical W7
2. Improving business portfolio management of Insuline Medical W7
3. Assessing feasibility of the new initiative in Israel
4. Making a sector specific business decision
5. Set goals for the organization
6. Organizational restructuring of Insuline Medical W7
Strengths of Insuline Medical W7 | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Insuline Medical W7 are -
Operational resilience
– The operational resilience strategy of Insuline Medical W7 comprises – understanding the underlying the factors in the industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.
Highly skilled collaborators
– Insuline Medical W7 has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive industry. Secondly the value chain collaborators of Insuline Medical W7 have helped the firm to develop new products and bring them quickly to the marketplace.
Learning organization
- Insuline Medical W7 is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Insuline Medical W7 is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders at Insuline Medical W7 emphasize – knowledge, initiative, and innovation.
High switching costs
– The high switching costs that Insuline Medical W7 has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.
Ability to recruit top talent
– Insuline Medical W7 is one of the leading players in the industry in Israel. It is in a position to attract the best talent available in Israel. The firm has a robust talent identification program that helps in identifying the brightest.
Low bargaining power of suppliers
– Suppliers of Insuline Medical W7 in the sector have low bargaining power. Insuline Medical W7 has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Insuline Medical W7 to manage not only supply disruptions but also source products at highly competitive prices.
Innovation driven organization
– Insuline Medical W7 is one of the most innovative firm in sector.
Diverse revenue streams
– Insuline Medical W7 is present in almost all the verticals within the industry. This has provided Insuline Medical W7 a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.
Analytics focus
– Insuline Medical W7 is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure of Israel is also helping it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
High brand equity
– Insuline Medical W7 has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Insuline Medical W7 to keep acquiring new customers and building profitable relationship with both the new and loyal customers.
Sustainable margins compare to other players in industry
– Insuline Medical W7 has clearly differentiated products in the market place. This has enabled Insuline Medical W7 to fetch slight price premium compare to the competitors in the industry. The sustainable margins have also helped Insuline Medical W7 to invest into research and development (R&D) and innovation.
Training and development
– Insuline Medical W7 has one of the best training and development program in industry. The effectiveness of the training programs can be measured in – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.
Weaknesses of Insuline Medical W7 | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of Insuline Medical W7 are -
Slow to harness new channels of communication
– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, Insuline Medical W7 is slow explore the new channels of communication. These new channels of communication can help Insuline Medical W7 to provide better information regarding products and services. It can also build an online community to further reach out to potential customers.
Lack of clear differentiation of Insuline Medical W7 products
– To increase the profitability and margins on the products, Insuline Medical W7 needs to provide more differentiated products than what it is currently offering in the marketplace.
Products dominated business model
– Even though Insuline Medical W7 has some of the most successful models in the industry, this business model has made each new product launch extremely critical for continuous financial growth of the organization. Insuline Medical W7 should strive to include more intangible value offerings along with its core products and services.
Aligning sales with marketing
– From the outside it seems that Insuline Medical W7 needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department at Insuline Medical W7 can leverage the sales team experience to cultivate customer relationships as Insuline Medical W7 is planning to shift buying processes online.
Increasing silos among functional specialists
– The organizational structure of Insuline Medical W7 is dominated by functional specialists. It is not different from other players in the industry, but Insuline Medical W7 needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help Insuline Medical W7 to focus more on services in the industry rather than just following the product oriented approach.
Need for greater diversity
– Insuline Medical W7 has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.
Compensation and incentives
– The revenue per employee of Insuline Medical W7 is just above the industry average. It needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.
No frontier risks strategy
– From the 10K / annual statement of Insuline Medical W7, it seems that company is thinking out the frontier risks that can impact industry. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.
High dependence on Insuline Medical W7 ‘s star products
– The top 2 products and services of Insuline Medical W7 still accounts for major business revenue. This dependence on star products in industry has resulted into insufficient focus on developing new products, even though Insuline Medical W7 has relatively successful track record of launching new products.
High operating costs
– Compare to the competitors, Insuline Medical W7 has high operating costs in the industry. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Insuline Medical W7 lucrative customers.
Workers concerns about automation
– As automation is fast increasing in the industry, Insuline Medical W7 needs to come up with a strategy to reduce the workers concern regarding automation. Without a clear strategy, it could lead to disruption and uncertainty within the organization.
Insuline Medical W7 Opportunities | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities of Insuline Medical W7 are -
Buying journey improvements
– Insuline Medical W7 can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. It can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.
Reforming the budgeting process
- By establishing new metrics that will be used to evaluate both existing and potential projects Insuline Medical W7 can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.
Finding new ways to collaborate
– Covid-19 has not only transformed business models of companies in industry, but it has also influenced the consumer preferences. Insuline Medical W7 can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.
Harnessing reconfiguration of the global supply chains
– As the trade war between US and China heats up in the coming years, Insuline Medical W7 can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help Insuline Medical W7 to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.
Use of Bitcoin and other crypto currencies for transactions in industry
– The popularity of Bitcoin and other crypto currencies as asset class and medium of transaction has opened new opportunities for Insuline Medical W7 in the industry. Now Insuline Medical W7 can target international markets with far fewer capital restrictions requirements than the existing system.
Loyalty marketing
– Insuline Medical W7 has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.
Leveraging digital technologies
– Insuline Medical W7 can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Learning at scale
– Online learning technologies has now opened space for Insuline Medical W7 to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.
Low interest rates
– Even though inflation is raising its head in most developed economies, Insuline Medical W7 can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.
Identify volunteer opportunities
– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Insuline Medical W7 can explore opportunities that can attract volunteers and are consistent with its mission and vision.
Developing new processes and practices
– Insuline Medical W7 can develop new processes and procedures in industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.
Using analytics as competitive advantage
– Insuline Medical W7 has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in sector. This continuous investment in analytics has enabled Insuline Medical W7 to build a competitive advantage using analytics. The analytics driven competitive advantage can help Insuline Medical W7 to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.
Better consumer reach
– The expansion of the 5G network will help Insuline Medical W7 to increase its market reach. Insuline Medical W7 will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.
Threats Insuline Medical W7 External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats of Insuline Medical W7 are -
Shortening product life cycle
– it is one of the major threat that Insuline Medical W7 is facing in sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.
New competition
– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Insuline Medical W7 in the sector and impact the bottomline of the organization.
Increasing wage structure of Insuline Medical W7
– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Insuline Medical W7.
High dependence on third party suppliers
– Insuline Medical W7 high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.
Easy access to finance
– Easy access to finance in industry will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Insuline Medical W7 can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.
Technology acceleration in Forth Industrial Revolution
– Insuline Medical W7 has witnessed rapid integration of technology during Covid-19 in the industry. As one of the leading players in the industry, Insuline Medical W7 needs to keep up with the evolution of technology in the sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.
Instability in the European markets
– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Insuline Medical W7 will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.
Regulatory challenges
– Insuline Medical W7 needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the industry regulations.
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Insuline Medical W7.
Trade war between China and United States
– The trade war between two of the biggest economies can hugely impact the opportunities for Insuline Medical W7 in industry. The industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Insuline Medical W7 business can come under increasing regulations regarding data privacy, data security, etc.
Increasing international competition and downward pressure on margins
– Apart from technology driven competitive advantage dilution, Insuline Medical W7 can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate Insuline Medical W7 prominent markets.
Technology disruption because of hacks, piracy etc
– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.
Weighted SWOT Analysis of Insuline Medical W7 Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers at Insuline Medical W7 needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of Insuline Medical W7 is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of Insuline Medical W7 is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of Insuline Medical W7 to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Insuline Medical W7 needs to make to build a sustainable competitive advantage.